Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2024	Jun. 30, 2023
Cash flows from operating activities:
Net loss	$ (536,626)	$ (956,288)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	12,951	13,661
Realized gain on marketable securities		(26,375)
ROU asset amortization	71,486	73,308
Bad debt recovery		(5,000)
Change in assets and liabilities:
Royalty receivables	(75,096)	(71,558)
Prepaid expenses and other assets	(107,898)	(130,791)
Accounts payable and accrued expenses	36,108	(35,741)
Deferred revenue	125,000	12,794
Operating lease liability	(103,897)	(96,925)
Net cash used in operating activities	(577,972)	(1,222,915)
Cash flows from investing activities:
Purchases of fixed assets	(154)	(1,304)
Purchases of marketable securities		(2,965,160)
Sales of marketable securities		2,991,535
Net cash (used in) provided by investing activities	(154)	25,071
Cash flows from financing activities:
Net proceeds from exercise of options and warrants	8,670	484,502
Net cash provided by financing activities	8,670	484,502
Net decrease in cash and cash equivalents	(569,456)	(713,342)
Cash and cash equivalents at beginning of period	2,475,958	4,230,916
Cash and cash equivalents at end of period	$ 1,906,502	$ 3,517,574